Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | NAMPT | P43490 | 6/20 | 0.83 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.77 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.77 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.73 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.71 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.71 |
| ▸ | CLK2 | P49760 | 1/20 | 0.69 |
| ▸ | CLK3 | P49761 | 1/20 | 0.69 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.69 |
| ▸ | NPC1 | O15118 | 2/20 | 0.69 |
| ▸ | RAB9A | P51151 | 2/20 | 0.69 |
| ▸ | GAA | P10253 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | PIM1 | P11309 | 1/20 | 0.67 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.67 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nicotinanilide SCHEMBL29067673 | 0.91 | LMNA (0.83) | LMNAHIF1ANAMPTROCK2ROCK1 | |
| Nicotinanilide SCHEMBL352439 | 0.91 | LMNA (0.83) | LMNAHIF1ANAMPTROCK2ROCK1 | |
| SCHEMBL167081 | 0.91 | NAMPT (1.00) | LMNAHIF1ANAMPTKCNK3CYP11B1 | |
| Nicotinanilide SCHEMBL8155304 | 0.89 | LMNA (0.81) | LMNAHIF1ANAMPTROCK2ROCK1 | |
| SCHEMBL30533390 | 0.89 | LMNA (0.81) | LMNAHIF1ANAMPTKCNK3CYP11B1 | |
| Hydrochloric Acid SCHEMBL27890956 | 0.89 | NAMPT (0.97) | LMNAHIF1ANAMPTKCNK3CYP11B1 | |
| SCHEMBL19520187 | 0.89 | LMNA (0.81) | LMNAHIF1ANAMPTROCK2ROCK1 | |
| SCHEMBL14880208 | 0.87 | ROCK2 (1.00) | LMNAHIF1ANAMPTROCK2ROCK1 | |
| SCHEMBL28007807 | 0.87 | NAMPT (0.81) | LMNAHIF1ANAMPTROCK2ROCK1 | |
| SCHEMBL12707716 | 0.85 | LMNA (0.73) | LMNAHIF1ANAMPTCYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028685-A1 | Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids | UNIV COLORADO REGENTS (US) | 2026-01-29 | — | — | US | claimed |
| WO-2021236696-A1 | SALIVA STABILIZATION SOLUTION FOR USE IN NUCLEIC ACID AMPLIFICATION REACTIONS AND METHODS OF USE FOR THE DETECTION OF PATHOGEN NUCLEIC ACIDS | THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE (US) | 2021-11-25 | — | — | WO | claimed |
| US-12590955-B2 | Methods and systems for processing particles | ZEON CORPORATION (JP) | 2026-03-31 | — | — | US | disclosed |
| US-20260071299-A1 | APPARATUS AND METHODS FOR RARE EARTH ELEMENT RECOVERY AND PURIFICATION | BATTELLE MEMORIAL INSTITUTE (US) | 2026-03-12 | — | — | US | disclosed |
| US-20250381163-A1 | Chelating Agents for Use in Cancer Therapy | PLECO THERAPEUTICS B V (NL) | 2025-12-18 | — | — | US | disclosed |
| US-12436081-B2 | Methods and devices for multi-step cell purification and concentration | ZEON CORPORTION (JP) | 2025-10-07 | — | — | US | disclosed |
| WO-2025089964-A1 | METHODS FOR TESTING ACTIVE COMPOUNDS IN MODELS WITH ELEVATED HEAVY METAL ACCUMULATION | PLECO THERAPEUTICS B.V. (NL) | 2025-05-01 | — | — | WO | disclosed |
| EP-4529456-A1 | CHELATING AGENTS FOR USE IN CANCER THERAPY | Pleco Therapeutics B.V. (NL) | 2025-04-02 | — | — | EP | disclosed |
| US-12258535-B2 | Emulsions having oil phase surfactants and water phase additive blends | PILOT CHEMICAL CORP. (US) | 2025-03-25 | — | — | US | disclosed |
| CN-119630394-A | Chelating agents for cancer treatment | 普雷高治疗有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20240368734-A1 | METHODS FOR EXTRACTING RARE EARTH ELEMENTS FROM RARE EARTH ELEMENT SOURCES | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | 2024-11-07 | — | — | US | disclosed |
| EP-2794569-A1 | HETEROCYCLIC UREA COMPOUNDS | Biota Europe Ltd (GB) | 2014-10-29 | — | — | EP | disclosed |
| WO-2014151491-A1 | METAL COMPLEXING AGENTS AS CORROSION INHIBITORS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014145152-A2 | ON-CHIP MICROFLUIDIC PROCESSING OF PARTICLES | GPB SCIENTIFIC, LLC (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014145075-A2 | METHODS AND DEVICES FOR HIGH THROUGHPOUT PURIFICATION | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20140031547-A1 | CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES | ELECTROPHORETICS LIMITED | 2014-01-30 | — | — | US | disclosed |
| WO-2013091011-A1 | HETEROCYCLIC UREA COMPOUNDS | BIOTA EUROPE LTD (GB) | 2013-06-27 | — | — | WO | disclosed |
| EP-2307409-A1 | PYRROLOPYRIDINES AS KINASE INHIBITORS | Array Biopharma, Inc. (US) | 2011-04-13 | — | — | EP | disclosed |
| WO-2009140320-A1 | PYRROLOPYRIDINES AS KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2009-11-19 | — | — | WO | disclosed |
| EP-1389618-A1 | PYRAZOLO 1,5-A]PYRIDINES AND MEDICINES CONTAINING THE SAME | Eisai Co., Ltd. (JP) | 2004-02-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071299-A1 | APPARATUS AND METHODS FOR RARE EARTH ELEMENT RECOVERY AND PURIFICATION | ERCC4, ERCC2, XPA | LMNA 556/4885HIF1A 825/4885NAMPT 3884/4885 |
| US-20260028685-A1 | Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids | RNASEH1, ACE2, DDX42 | LMNA 3512/4885HIF1A 2730/4885NAMPT 2292/4885 |
| US-20140031547-A1 | CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES | CSNK1G1, CSNK1A1, CSNK1G3 | LMNA 1627/4885HIF1A 1940/4885NAMPT 2344/4885 |
| US-12590955-B2 | Methods and systems for processing particles | EZR, CD47, CD44 | LMNA 571/4885HIF1A 2068/4885NAMPT 3975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.